Malcisbo develops novel carbohydrate-based vaccines for human & animal health. Based on a novel platform technology, we develop vaccines against bacterial and parasitic diseases.
Our development projects are:
Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2017)
Malcisbo participates in a CTI-funded research project on the development of a vaccine against APP.
Collaboration with a pharma company
R&D collaboration with a pharma company targeting our Campylobacter vaccine.
Phone: +41 44 732 22 00
E-Mail: info [SECURE E-MAIL - REWRITE MANUALLY] *at* malcisbo *dot* com
© Copyright Malcisbo AG